Cellectis (CLLS) Deferred Taxes (2015 - 2023)
Cellectis (CLLS) recorded quarterly Deferred Taxes of -$98000.0 in Q2 2023, down 135.25% quarter-over-quarter from $278000.0 in Q1 2023, and up 19.67% on a YoY basis from -$81890.4 in Q2 2022.
Cellectis (CLLS) Deferred Taxes (2015 - 2023) Analysis & Trends
Cellectis' Deferred Taxes history runs 9 years deep, the most recent figure standing at -$98000.0 for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -98,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Sep 30, 2022 | -211,000.00 |
| Jun 30, 2022 | -122,000.00 |
| Mar 31, 2022 | 324,000.00 |
| Sep 30, 2021 | 81,000.00 |
| Jun 30, 2021 | 160,000.00 |
| Mar 31, 2021 | -179,000.00 |
| Sep 30, 2020 | -450,000.00 |
| Jun 30, 2020 | -53,000.00 |
| Mar 31, 2020 | -19.11 Mn |
| Sep 30, 2019 | 75,000.00 |
| Jun 30, 2019 | 148,000.00 |
| Mar 31, 2019 | -94,000.00 |
| Sep 30, 2018 | 88,000.00 |
| Jun 30, 2018 | -3.45 Mn |
| Mar 31, 2018 | -3.62 Mn |
| Sep 30, 2017 | -4.01 Mn |
| Jun 30, 2017 | -4.91 Mn |
| Mar 31, 2017 | -4.06 Mn |